Autolus Therapeutics Ltd reported $-47.92M in Net Income for its fiscal quarter ending in June of 2025.





Net Income Change Date
AstraZeneca USD 2.53B 83M Sep/2025
Autolus Therapeutics Ltd USD -47.92M 22.24M Jun/2025
Hikma Pharmaceutical USD 119M 14M Jun/2025
Novartis USD 3.93B 96M Sep/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Silence Therapeutics USD -27.01M 11.45M Sep/2024